Skip Navigation

This Article
Right arrow Abstract Freely available
Right arrow Print PDF (938K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (540)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Nickerson, D. A.
Right arrow Articles by Taylor, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nickerson, D. A.
Right arrow Articles by Taylor, S. L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1995 Oxford University Press 2745-2751

PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing

PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing Deborah A. Nickerson*, Vincent O. Tobe and Scott L. Taylor

Department of Molecular Biotechnology, Box 357730, University of Washington, Seattle, WA 98195-7730, USA

Received April 22, 1997; Revised and Accepted May 27, 1997

ABSTRACT

Fluorescence-based sequencing is playing an increasingly important role in efforts to identify DNA polymorphisms and mutations of biological and medical interest. The application of this technology in generating the reference sequence of simple and complex genomes is also driving the development of new computer programs to automate base calling (Phred), sequence assembly (Phrap) and sequence assembly editing (Consed) in high throughput settings. In this report we describe a new computer program known as PolyPhred that automatically detects the presence of heterozygous single nucleotide substitutions by fluorescencebased sequencing of PCR products. Its operations are integrated with the use of the Phred, Phrap and Consed programs and together these tools generate a high throughput system for detecting DNA polymorphisms and mutations by large scale fluorescence-based resequencing. Analysis of sequences containing known DNA variants demonstrates that the accuracy of PolyPhred with single pass data is >99% when the sequences are generated with fluorescent dye-labeled primers and ~90% for those prepared with dye-labeled terminators.

INTRODUCTION

Single base substitutions are the most frequent form of DNA sequence variation in the human genome (1 ,2 ). Identification of these variations plays an important role in detailing the evolutionary history of human populations (3 ,4 ) and in exploring the relationships between genome structure and function (genotype-phenotype correlations) through genetic and disequilibrium mapping (5 ,6 ). Furthermore, many diagnostic applications depend on accurate identification of single nucleotide substitutions for finding mutated genes (7 ,8 ), matching tissues prior to transplantation (9 ) and analyzing samples in forensic situations (10 ).

Amplification of specific genomic regions using PCR has greatly simplified the process of comparing sequences to identify DNA variations by eliminating the need for genomic cloning from multiple individuals (11 ). Once a region has been amplified, a number of techniques can be employed to comparatively scan it for sequence variants. These include denaturing gradient gel electrophoresis (12 ), chemical or enzymatic cleavage (13 -15 ), heteroduplex analysis (16 ), the analysis of single-stranded DNA conformations (17 ), hybridization to oligonucleotide arrays (18 ,19 ) and DNA sequencing (20 -22 ). Among these approaches, DNA sequencing offers several advantages, including its ease of application (use of a single set of reagents and assay conditions), its automation with fluorescence-based methods and its ability to provide complete information about the location and nature of the sequence variant(s) in a single pass.

Despite the advantages of detecting DNA variations by sequence analysis, it is difficult to accurately identify heterozygous sites (two bases at the same location in a sequence) because of the variability in fluorescence signals and the inconsistency of base calling at these sites. Recently, several approaches have been taken to improve identification of heterozygous sites using automated sequence analysis (22 -25 ). In one approach, heterozygotes are found by comparing the pattern of fluorescence dye incorporation between the sequence traces (22 ). Since this pattern is faithfully reproduced every time the same sequence is generated, heterozygous positions in a trace can be accurately identified based on a predictable reduction (~50%) in normalized peak area when compared with homozygous positions. In this report we present a computer program known as PolyPhred that automatically finds potential heterozygotes in a sequence using this comparative approach. We also compare program performance with sequencing chemistries that produce highly variable patterns of dye incorporation (sequences generated with dye-labeled terminators; 26 ) and those that produce more uniform fluorescence incorporation (dye-labeled primer sequencing) in terms of their accuracy and efficiency in heterozgyote detection. Lastly, we report the discovery of new DNA variations using comparative sequencing and PolyPhred.

MATERIALS AND METHODS

PCR primers

Primers for PCR amplification of genomic DNA were assembled using standard phosphoramidite chemistry on an Applied Biosystems 394 DNA synthesizer (Foster City, CA). Primers were prepared and used to amplify 11 genomic regions containing single nucleotide substitutions representing all potential nucleotide changes (A <-> T, A <-> C, G <-> T, C <-> G, A <-> G, C <-> T). The regions examined were: (i) exon 2 of the human steroid 5[alpha]-reductase gene (SRD5A1, A <-> G, GDB:193189, CCCAAATCATTTAAGATAGGATTAC, ATGATGTGAACAAGGCGGAGTTCAC, 60oC); (ii) intron 8 of the human lipoprotein lipase gene (LPL, A <-> C, GDB:191079, TACACTAGCAATGTCTAGCTGA, TCAGCTTTAGCCCAGAATGC, 60oC); (iii) exon 28 of the von Willebrand factor pseudogene (VWFP, A <-> T, GDB:194282, TGTAAAACGACGGCCAGT(-21M13)AGCCGTCGTGGTACTCCACCACA, CAGGAAACAGCTATGACC(M13Rev)AGATTCTGTGGGAATATGGAAGTAGTCA, 55oC); (iv) exon 5 of the guanine nucleotide binding protein (GNAS, A <-> G, GDB:203981, TCTTGTAGCGCCCTCCCA, TGCCCATGTGCAGGGCTGTCACTCATGTT, 60oC); (v) a segment from the 3'-untranslated region of [beta]2-integrin (ITGB2, C <-> T, GDB:185175, GAGCACTTGGTGAAGACAAG, GGATGTCATTTTATACCCTG, 51oC); (vi) intron 3 of adenine nucleotide translocator 1 (ANT1, C <-> T, GDB:201792, ACAGGGCTCCTTTCAGTCTTCC, CAAATGCTGGTGAGGGCTCCG, 57oC); (vii) exon 4a of solute carrier family 2, member 4 (SLC2A4, C <-> T, GDB:180271, CAGGAAGGGAGCCACTGCTG, ATCTGAAAGCCCAGGCATGG, 63oC); (viii) a segment from the 3'-untranslated region of the tyrosinase-related protein 1 gene (TYRP1, A <-> C, GDB:555709, GTCGGGAGTTTAGTGTACCT, TCTGAAAGGGTCTTCCCAGC, 60oC); (ix) intron 4 of the constant region of the human T cell receptor (TCR) [alpha] locus (TCRCA, C <-> T, G <-> T and C <-> G, TGTAAAACGACGGCCAGT(-21M13)GAGCTAAGAGAGCCGTACTGG, CAGGAAACAGCTATGACC(M13Rev)CTTGAAGCTGGGAGTGG, 55oC) (27 ); (x) a variable gene segment from the human TCR [alpha] locus (TCRVA23, C <-> T and C <-> G, TGTAAAACGACGGCCAGT- (-21M13)GTCTAAGTGACAGAAGGAATG, AATGTATAAAGTACTACGTCCTGA, 55oC) (28 ); (xi) a variable gene segment from the human TCR [beta] locus (TCRVB23, A <-> G and G <-> T, GenBank accession no. U96844, TGTAAAACGACGGCCAGT- (-21M13)GGAAAGCCTGAGTTAGCTGAGC, CAGGAAACAGCTATGACC(M13Rev)AGAATAGAAGCATCTCTGGG, 55oC).

DNA amplification

DNA samples from the parents of the 40 families available through the Centre d'Etude du Polymorphisme Humaine (CEPH) were used for PCR amplification of the target loci. All amplification reactions were performed in a 96-well microtiter plate thermal cycler (PTC 100; MJ Research, Watertown, MA). The reactions were assembled (20 [mu]l total volume) and contained a standard PCR buffer (10 mM Tris-HCl, pH 8.3, 50 mM KCl, 1.5 mM MgCl2 and 0.001% gelatin), the four deoxynucleotide triphosphates at 40 [mu]M each, 0.5 [mu]M each primer, 0.5 U Taq polymerase (Perkin Elmer Cetus, Norwalk, CT) and 20 ng genomic DNA. Following assembly, the reactions were covered with 50 [mu]l mineral oil. Thermal cycling was performed with an initial denaturation at 94oC for 1 min followed by 35 cycles of denaturation at 95oC for 20 s, primer annealing for 30 s (temperatures specified above with primer sequences) and primer extension at 72oC for 2 min. After 35 cycles, a final extension was carried out at 72oC for 5 min. Individuals were selected for DNA amplification based on genotypes previously established in these loci using PCR combined with an oligonucleotide ligation assay (OLA; 29 ).

DNA sequencing

Following DNA amplification, unincorporated PCR primers and deoxynucleotide triphosphates in the samples were inactivated prior to sequencing by enzymatic treatment. This was accomplished by mixing 6 [mu]l PCR product with 1 [mu]l exonuclease I (10 U/[mu]l; Amersham Life Science Inc., Arlington Heights, IL) and 1 [mu]l shrimp alkaline phosphatase (2 U/[mu]l; Amersham) and incubating at 37oC for 15 min followed by 80oC for 15 min to inactivate the exonuclease and alkaline phosphatase enzymes prior to sequencing. In our hands PCR products treated with these enzymes sequence as well in terms of quality and read length as those isolated by agarose gel electrophoresis coupled with column purification (26 ). Cycle sequencing was performed according to the manufacturer's instructions using ABI PRISM Dye Terminator or Dye Primer Sequencing Kits with Amplitaq DNA polymerase FS (Perkin Elmer Corp., Foster City, CA). For dye-terminator cycle sequencing the entire enzyme-treated PCR sample (8 [mu]l total following treatment) was used as the sequencing template. The sequencing primer (3.2 pmol, same as PCR primer) and 8 [mu]l Dye Terminator Ready-Reaction sequencing premix were added to the template. Following a denaturation step at 96oC for 2 min, dye-terminator reactions were incubated at 96oC for 15 s, 50oC for 1 s and 60oC for 4 min for 25 cycles. Excess dye-terminators were removed by ethanol precipitation. In the case of dye-primer sequencing, PCR products were generated using locus-specific primers containing either the -21M13 or M13Rev primer sequences at their 5'-end. For sequencing the enzyme-treated PCR sample was subdivided into four separate reactions as follows: 1 [mu]l each of the PCR sample mixed with 4 [mu]l PRISM ready premix for the A and C reactions and 2 [mu]l each of the PCR sample mixed with 8 [mu]l PRISM ready premix for the G and T reactions. Sequencing reactions were denatured for 1 min at 96oC and subjected to 15 cycles at 96oC for 10 s, 55oC for 5 s and 70oC for 1 min and 15 cyles at 96oC for 10 s and 70oC for 1 min. Then, the A, C, G and T reactions were pooled and subjected to ethanol precipitation. The extension products obtained with either chemistry were evaporated to dryness under pressure (Savant Instruments, Farmingdale, NY), resuspended in 3 [mu]l loading buffer (5:1, 1% deionized formamide, 50 mM EDTA, pH 8.0), heated for 2 min at 90oC and loaded onto an Applied Biosystems 373 sequencer according to the manufacturer's directions.

Sequence analysis

The ABI sequence software (version 2.1.2) was used for lane tracking and first pass base calling (Perkin Elmer). Chromatograms were transferred to a Unix workstation (Sun Microsystems Inc., Mountain View, CA), base called with Phred (version 0.961028), assembled with Phrap (version 0.960731), scanned by PolyPhred (version 0.970312) and the results viewed with the Consed program (version 4.0). Specific descriptions and documentation on Phred, Phrap and Consed are available at http://www.genome. washington.edu (P.Green, personal communication). PolyPhred has been designed to parse information from Phred and Phrap output files and via a flat file provide input to Consed to aid in identification of heterozygous single nucleotide substitutions by color coding potential sites. All data presented in this report were generated using command line parameters requiring a peak drop ratio of 0.55, a second peak ratio of 0.15 and, unless noted otherwise, an average sequence quality setting of 30. PolyPhred is available via Email from debnick@u.washington.edu and more documentation is available at http://droog.mbt.washington.edu.


Figure 1. Two windows from the `color means quality and tags view' of the Consed program. Sequences from two TCR [beta] sites (in TCRVB23) obtained by dye-primer sequencing of PCR products from 10 different individuals are shown in each window. In Consed, sequence quality measured by Phred is depicted using a gray scale with a white background indicating the highest quality bases and increasing shades of gray indicating decreasing data quality. Potential heterozygotes identified by PolyPhred are color coded in blue in this Consed view. (a) When a common DNA polymorphism is identified (e.g. position 214) homozygotes for each of the alternative alleles and heterozygotes (highlighted blue) are normally detected.(b) Less common DNA variants usually appear as rare heterozygotes among a background of homozygotes (e.g. position 351). There are no false positives or false negatives identified in these windows and the genotypes of these individuals were completely consistent with those obtained by PCR/OLA.

RESULTS

In comparing sequence traces of homozygotes with those for heterozygotes two changes are usually present: (i) a significant drop in normalized peak height at a polymorphic site when traces from homozygous and heterozygous individuals are compared; (ii) a second underlying peak at the position in question (22 ,26 ). To automate identification of substitution variations using these criteria, we created a program known as PolyPhred. Its functions are fully integrated with three software packages currently applied in large scale sequence analysis: Phred, Phrap and Consed (P.Green, B.Ewing and D.Gordon, personal communication). PolyPhred reads the normalized peak areas and quality values obtained by Phred for each position in a sequence. It then searches for reductions in peak areas at each position across the sequence alignment obtained from the Phrap assembly program. If the required drop in peak area is found at a position and a second base is detected by Phred, PolyPhred calls the site a potential heterozygote and information on this position is stored in the program's output file.

By interfacing the information obtained by PolyPhred with the `quality means color and tags view' in the Consed program, potential heterozygotes become color coded, as shown in Figure 1 (position 214, Fig. 1 a, and position 351, Fig. 1 b). In these examples Consed views of sequences from 10 individuals are shown. Heterozygotes at two positions in the coding region of a TCR gene were automatically identified by PolyPhred (91 bp of assembly sequence are shown in each window and, altogether for the 10 individuals, 1820 bp of sequence are displayed). When a common polymorphism is identified (position 214 in Fig. 1 a, His -> Arg substitution) homozygotes for each of the alternative alleles are detected (e.g. in this instance four individuals homozygous G and one individual homozygous A), in addition to heterozygotes containing the two alternative alleles (e.g. sequences from the five heterozygous individuals color coded blue). However, less common alleles will typically be identified just as heterozygotes among the homozygotes (e.g. the three heterozygotes color coded blue at position 351 in Fig. 1 b). It is worth noting that the variant at position 351 (Val -> Gly) would have been missed if identification was based solely on the results of sequence alignment, since neither the ABI nor the Phred program called these positions as Ns: in all cases the G peak was sufficiently dominant even in a heterozygote to meet the ABI and Phred criteria for a G.

Table 1 . Sequence quality and PolyPhred performance
Chemistry

 

PolyPhred quality threshold

Average quality of data analyzed Truea positives (TP)

False positives (FP)

Total bases scanned

Ratiob TP/FP

 

Dye-primer 20 36 147 1545 61 947 1:11
25 37 147 811 57 915 1:6
  30 38 146 381 53 472 1:3
  35 40 143 179 47 517 1:1
  40 42 107 54 34 419 2:1
Dye-terminator 20 29 202 2637 81 479 1:13
  25 31 197 1662 73 750 1:8
  30 32 173 768 62 772 1:4
  35 35 104 245 42 091 1:2
  40 39 28 31 16 711 1:1
aIncludes variations previously identified in target loci and typed by PCR/OLA in addition to new variations detected and confirmed by sample resequencing.
bThe ratio of true positives to false positives rounded to the nearest whole number.


Figure 2. Examples of two polymorphic sites identified by PolyPhred in TCRVB23; position 214(a and b) and position 351 (c and d). An example of a homozygote (a and c) and heterozygote (b and d) for each of these sites has been isolated from a trace editor window opened by the Consed program. Base calls for the consensus (con), edited (edt, where PolyPhred color codes heterozygotes), the Phred (phd) and ABI (ABI) programs are shown. When traces are opened in Consed, the sequence position used to open the file is indicated by the vertical white line. Note that in the heterozygotes (b and d) there is a significant drop in peak height in the Gs and a second peak is found in the heterozygotes (b, G/A; d, G/T), but not in the homozgyotes (a and c).

Once potential heterozygotes are tagged in Consed, the traces can be viewed by the analyst for editing or evaluation purposes. Examples of homozygous and heterozygous sequencing traces taken from Consed are shown in Figure 2 . When comparing homozygous and heterozygous sequencing traces (as in Fig. 2 ), a characteristic drop in peak height (area) is obvious and a significant signal for a second base is present in the heterozygous sequences. With sequencing chemistries that produce more uniform fluorescence peaks (i.e. dye-labeled primer sequencing) the two peaks in a heterozygote are usually similar in size and are frequently called Ns. However, many heterozygous sites (~35%) will still be missed and called as homozygotes because of the peak disparity between the bases (position 351, Fig. 2 d). This problem is even greater for chemistries that give rise to more uneven fluorescence incorporation (26 ). For example in dye-terminator sequencing >70% of the heterozygotes are called as homozygotes.

One of the key features of the Phred/Phrap/Consed environment is that data quality is monitored and displayed as an integral part of the system. By operating in this environment we have found that there is a clear relationship between sequence quality (determined by Phred) and PolyPhred performance (Table 1 ). Three factors are used to generate quality measures in Phred; these include peak spacing, the relative size of the uncalled and called peaks and the dip in signal between called peaks (B.Ewing and P.Green, personal communication). As expected when sequence quality is low (Phred quality = 20), the signal-to-noise ratio as measured by the ratio of PolyPhred true positives (confirmed by PCR/OLA, 92%, or by sample resequencing, 8%) to false positives is low (Table 1 ). With PCR products <700 bp in length this quality setting allows nearly complete scanning of all the bases in each trace, including the low quality bases at the start and end of the sequence. However, even at this modest quality level, the total positives identified by PolyPhred are <3% of the total base pairs examined.

The signal-to-noise ratio (true positive to false positives) improves greatly as the scanning window for PolyPhred is set to analyze data at increasing quality thresholds. The total number of base pairs that can be scanned at higher quality settings differs significantly for the two chemistries examined. With dye-primer sequencing and a quality setting of 40, an average of 250 bp are scanned in 94% of the available sequence traces (143 traces altogether) and the signal-to-noise ratio is 2:1 (Table 1 ). At higher qualities, false positives are easily distinguished by an analyst and are usually caused by a fluctuation in peak height from a homozgyote combined with some increase in the background noise that led PolyPhred to detect a second base. Examples of these types of false positives are shown in Figure 3 for sequences produced with dye-labeled primer (Fig. 3 a and b) or dye-labeled terminator (Fig. 3 c and d) sequencing.


Figure 3. Examples of false positive calls made by Polyphred. In dye-primer sequencing, a correctly called non-variant site (a) compared with a false positive (b).This false positive is triggered by premature termination in the sequencing products and generates a low quality base in a high quality region. In dye-terminator sequencing, random peak fluctuations associated with small peak contexts such as Gs after As (c) and background noise will often trigger a false positive call (d) by PolyPhred.

In terms of PolyPhred's performance, sequencing with dye- labeled primers has many advantages over sequencing with dye- labeled terminators (Table 1 ). Across the range of sequence quality the ratios of signal-to-noise for sequences generated with dye-labeled primers are nearly twice those observed with dye- labeled terminator sequencing (Table 1 ). The incorporation of dye-labeled terminators is known to produce uneven peaks which will impact sequence quality by their effects on peak areas (26 ). Furthermore, the predictable sequence patterns that are produced also greatly influence the number of false positives produced by PolyPhred. In fact, >50% of the false positives identified by PolyPhred were associated with sequence contexts that produce small peaks with dye-labeled terminators (26 ). A single sequence context, the small G peaks that follow A peaks, was associated with >30% of all the false positives identified with this sequencing chemistry (Fig. 3 d).

To measure accuracy in calling heterozygotes, we compared the genotypes determined by PolyPhred using a moderate quality level (30) with those previously determined by PCR/OLA. These results are shown in Table 2 and are broken down by sequencing chemistry and substitution composition. With single pass sequence data PolyPhred was able to achieve >99% accuracy in calling heterozyotes when sequences were generated using the dye-primer chemistry, i.e. 134 of 135 PolyPhred genotypes were correctly identified when compared with genotypes obtained by PCR/OLA. Upon examination of the data associated with the missed C/T heterozygote, we found that although there was an appropriate peak drop at this position, a second peak was not detected at the position by Phred. In our experience this is unusual for sequences generated with dye-labeled primers. With sequences generated with dye-labeled terminators, the overall accuracy of PolyPhred was nearly 90% (131 of 146 heterozygotes), but the errors were not evenly distributed among the different substitution types. Changes involving Cs and Gs were clearly more difficult to call. Approximately 35% of the heterozygotes of this composition were incorrectly called as homozygotes by PolyPhred. The other three substitutions (all C/T) were missed because the peak drop was not sufficient (reflecting fluctuations in dye incorporation).

In addition to the DNA variations typed and compared with OLA genotypes, nine new single nucleotide substitutions were identified by PolyPhred. These variants are summarized in Table 3 and all have been confirmed by resequencing. Although several of the variations (SRD5A1 and VWFP) were frequent, these results also document the program's sensitivity in terms of identifying single heterozygotes among homozygotes, e.g. three non-coding variants were detected in the TCRVA23 gene as single heterozygotes among 22 homozygotes (Table 3 ).

Table 2 . Efficiency of heterozygote detection by PolyPhred
Chemistry Base substitutions Totals
 

A/C A/G A/T C/G C/T G/T  
Dye-primer
PCR/OLA genotypes 18 14 17 26 36 24 135
PolyPhred calls
True positive 18 14 17 26 35 24 134
True negative 0 0 0 0 0 0 0
False positive 0 0 0 0 0 0 0
False negative 0 0 0 0 1 0 1
Dye-terminator
PCR/OLA genotypes 17 14 17 34 41 23 146
PolyPhred calls
True positive 17 14 17 22 38 23 131
True negative 0 0 0 0 0 0 0
False positive 0 0 0 0 0 0 0
False negative 0 0 0 12 3 0 15

DISCUSSION

Resequencing of genes to identify DNA variations will play a major role in the post-genomics analysis of human biology and medicine (2 -10 ). In this regard, high density oligonucleotide arrays are currently under testing for many types of resequencing projects (18 ,19 ). However, four-color fluorescence-based sequencing is currently a more mature technology capable of high throughput and with its increasing availability, decreasing cost and improving accuracy will likely be applied in many areas of genome resequencing. This is particularly true in those situations where little is known about the types and/or the distribution of the DNA variations within a sequence. Indeed, fluorescence-based sequencing is already frequently applied for diagnostic purposes (7 ,8 ,10 ,20 ,21 ,24 ).

Programs that automate analysis of high throughput fluorescence-based sequencing, such as Phred, Phrap and Consed, are rapidly emerging and we have integrated the use of PolyPhred with these large scale software tools. With regard to base calling, one of the significant advantages of Phred is its ability to provide quality measures for each base in a sequence. For some applications, such as shotgun sequencing of M13 templates with dye-labeled primers, quality can be related to an objective estimate of base calling error rate (P.Green, unpublished observation). Similar correlations between quality and base calling error are not yet available for PCR product sequencing and it is important to consider developing these standards, particularly for diagnostic resequencing (10 ,19 ). In these applications quality control is essential, as is assay standardization. Impartial measures of quality from programs such as Phred can help in further automating data analysis for large scale resequencing, just as it does in generating the reference sequence [e.g. setting base (or even whole sequence trace) inclusion or exclusion standards and providing an estimate of error and accuracy for every base call in a sequence]. Furthermore, these standards could be used to monitor the efficiency or effectiveness of new protocols and in the development of new applications, such as PolyPhred, where sequence quality can be related to performance standards.

Table 3 . New DNA variations detected by PolyPhred
Gene Sequence contexta Referenceb
allele
Frequencyc
TCRCA TTAGGGACG(C/T)GGGTCTCTG M94081 C 9%/T 91% (58)
LPL CTGAACACC(A/G)GGTTAGGCT M76722 A 9%/G 91% (54)
VWFP CCTGGTGGT(A/G)CCTCCCACA M60676 A 50%/G 50% (82)
SRD5A1 AATTTACCC(G/A)TTTCTGATG M68883 G 50%/A 50% (32)
ITGB2 AGCCATGGC(C/A)GGCCGGGTG X63926 C 80%/A 20% (40)
ANT1 TGAACCATA(T/C)GAAATTGCC J04982 T 42%/C 58% (14)
TCRVA23 AATTTAAAG(G/A)TAATTTCTA U32531 G 98%/A 2% (46)
TCRVA23 AAATGGAAA(T/A)GAGCAAAGA U32531 T 98%/A 2% (46)
TCRVA23 CTGCAATGT(G/T)AGTTAGAGG U32531 G 98%/T 2% (46)
aThe alternative alleles are presented in parentheses. The first allele is the one reported in the reference sequence.
bGenBank and EMBL accession nos for the reference allele sequence.
cAllele frequency among the test panel with the number of chromosomes typed by PolyPhred in parentheses.

One of the major challenges in identifying DNA variations by fluorescence-based approaches is related to the detection of two bases at a single position within a sequence. This is a difficult problem since the signal levels in a heterozygous sample will be 50% of that obtained with a homozygous sample. However, this drop in signal intensity can be used to comparatively and accurately detect heterozygotes among homozygotes (22 ). We found that this feature alone, although sensitive, is not specific enough in heterozygote detection because of fluctations in the sequencing traces. To increase specificity we also require the presence of a second underlying peak. This additional requirement does increase the specificity of heterozygote detection, but slightly decreases its sensitivity. In this report the absence of a detectable second peak by Phred clearly led to some errors (false negatives) in heterozygote detection by PolyPhred using single pass sequences. Although new approaches to trace normalization may help with the initial identification of second peaks by Phred, we are also evaluating whether the use of additional information associated with changes in the local sequence context due to the presence of a sequence variation, i.e. 3'-base effect (22 ), can help in improving the accuracy of heterozygote identification.

Several different fluorescence-based chemistries can now be applied in diagnostic resequencing and new ones are under development (30 ,31 ). In principle, any fluorescence-based chemistry that can be analyzed using the Phred, Phrap and Consed programs could also be scanned for DNA variations using PolyPhred. In terms of program performance, however, more uniform incorporation of the fluorescence dyes does yield higher accuracies in identifying heterozygotes with single pass data, i.e. comparing dye-primer performance (more uniform peaks with >99% accuracy) versus dye-terminator performance (uneven peaks with ~90% accuracy). In diagnostic situations where accuracy is essential, e.g. mutation scanning for genetic diseases or sequencing major histocompatibility genes for tissue typing, it is clear that chemistries that give rise to more uniform dye incorporation should be applied to the genes of interest and sequencing of the opposite strand should also be considered. However, in cases where one is not interested in finding every variant but needs to quickly scan a region for additional genetic markers (32 ), then dye-terminator-based chemistries combined with PolyPhred can identify a large number of the variants present among individuals scanned (~90% at quality 30).

The current version of PolyPhred is capable of identifying single nucleotide substitutions and although these variations are the most frequent basis for disease-causing mutations, automating the identification and typing of insertions and deletions of one or more base pairs in a sequence will also be important (8 ,18 ). A trained analyst can easily detect and resolve these variations. However, the development of a computationally efficient and accurate system for calling insertion/deletion variations will be challenging and this is a focus of our current work with PolyPhred.

In summary, there are many approaches being applied to detect DNA polymorphisms and mutations (33 ). Among these, direct sequencing serves as the gold standard in terms of sensitivity and accuracy (33 ). This, combined with new tools like PolyPhred, is rapidly making automated fluorescence-based resequencing a sensible and cost effective approach for identifying DNA polymorphisms and mutations in many biological and medical applications.

ACKNOWLEDGEMENTS

We thank Drs Phil Green and Brent Ewing and Mr David Gordon for sharing their insights and programs (Phred, Phrap and Consed) with us. We also thank Drs Maynard Olson and Mark Rieder and Ms Ursula Petralia for their helpful comments. This work was supported in part by the National Science Foundation (DIR 8809710), the National Institute for Human Genome Research (HG01436) and the Department of Energy (DE-FG03-97ER- 62385).

REFERENCES

1 Cooper,D.N., Smith,B.A., Cooke,H.J., Niemann,S. and Schmidtke,J. (1985) Hum. Genet., 69, 201-205. MEDLINE Abstract

2 Cooper,D.N. and Krawczak,M (1993) Human Gene Mutation. Bios Scientific, Oxford, UK.

3 Wallace,D.C. (1994) Proc. Natl. Acad. Sci. USA, 91, 8739-8746. MEDLINE Abstract

4 Erlich,H.A., Bergstrom,T.F., Stoneking,M. and Gyllensten,U. (1996) Science, 274, 1552-1554. MEDLINE Abstract

5 Trivier,E., DeCesare,D., Jacquot,S., Pannetier,S., Zackai,E., Young,I., Mandel,J.L., Sassone-Corsi,P. and Hanauer,A. (1996) Nature, 384, 567-570. MEDLINE Abstract

6 DeKok,Y.J., van der Maarel,S.M., Bitner-Glindzicz,M., Huber,I., Monaco,A.P., Malcolm,S., Pembrey,M.E., Ropers,H.H. and Cremers,F.P. (1995) Science, 267, 685-688.

7 Hedrum,A., Pont'en,F., Ren,Z., Lundeberg,J., Pont'en,J. and Uhl'en,M. (1994) BioTechniques, 17, 118-119, 122-124, 126-129. MEDLINE Abstract

8 Shattuck-Eidens,D., McClure,M. and Simard,J. (1995) J. Am. Med. Ass., 273, 535-541.

9 Santamaria,P., Boyce-Jacino,M.T. and Lindstrom,A.L. (1992) Hum. Immunol., 33, 69-81. MEDLINE Abstract

10 Wilson,M.R., DiZinno,J,A., Polanskey,D., Replogle,J. and Budowle,B. (1995) Int. J. Legal Med., 108, 68-74. MEDLINE Abstract

11 Saiki,R.K., Gelfand,D., Stoffel,S., Scharf,S.J., Higuchi,R., Horn,G.T., Mullis,K.B. and Erlich,H.A. (1988) Science, 239, 487-491. MEDLINE Abstract

12 Sheffield,V.C., Cox,D.R., Lerman,L.S. and Myers,R.M. (1989) Proc. Natl. Acad. Sci. USA, 86, 232-236. MEDLINE Abstract

13 Cotton,R.G., Rodrigues,N.R. and Campbell,R.D. (1988) Proc. Natl. Acad. Sci. USA, 85, 4397-4401. MEDLINE Abstract

14 Myers,R.M., Larin,Z. and Maniatis,T. (1985) Science, 230, 1242-1246. MEDLINE Abstract

15 Youil,R., Kemper,B.W. and Cotton,R.G. (1995) Proc. Natl. Acad. Sci. USA, 92, 87-91. MEDLINE Abstract

16 Glavac,D. and Dean,M. (1995) Hum. Mutat., 6, 281-287. MEDLINE Abstract

17 Orita,M., Suzuki,Y., Sekiya,T. and Hayashi,K. (1989) Genomics, 5, 874-879. MEDLINE Abstract

18 Hacia,J.G., Brody,L.C., Chee,M.S., Fodor,S.P.A. and Collins,F.S. (1996) Nature Genet., 14, 441-447. MEDLINE Abstract

19 Chee,M.S., Yang,R, Hubbell,E., Berno,A., Huang,X.C., Stern,D., Winkler,J., Lockhart,D.J., Morris,M.S. and Fodor,S.P. (1996) Science, 274, 610-614.

20 Gibbs,R.A., Nguyen,P.N., McBride,L.J., Koepf,S.M. and Caskey,T.M. (1989) Proc. Natl. Acad. Sci. USA, 86, 1919-1923. MEDLINE Abstract

21 Leren,T.P., Rodningen,O.K., Rosby,O., Solberg,K. and Berg,K. (1993) BioTechniques, 14, 618-623. MEDLINE Abstract

22 Kwok,P.-Y., Carlson,C., Yager,T.D., Ankener,W. and Nickerson,D.A. (1994) Genomics, 23, 138-144. MEDLINE Abstract

23 Phelps,R.S., Chadwick,R.B., Conrad,M.P., Kronick,M.N. and Kamb,A. (1995) BioTechniques, 19, 984-989. MEDLINE Abstract

24 Versluis,L.F., Rozemuller,E., Tonks,S., Marsh,S.G., Bouwens,A.G.M., Bodmer,J.G. and Tilanus,M.G.J. (1993) Hum. Immunol., 38, 277-283. MEDLINE Abstract

25 Hattori,M., Shibata,A., Yoshioka,K. and Sakaki,Y. (1993) Genomics, 15, 415-417. MEDLINE Abstract

26 Parker,L.T., Zakeri,H., Deng,Q., Kwok,P.-Y. and Nickerson,D.A. (1996) BioTechniques, 21, 694-699. MEDLINE Abstract

27 Nickerson,D.A., Whitehurst,C., Boysen,C., Charmley,P., Kaiser,R. and Hood,L. (1992) Genomics, 12, 377-387. MEDLINE Abstract

28 Boysen,C., Carlson,C., Hood,E., Hood,L. and Nickerson,D.A. (1996) Immunogenetics, 44, 121-127. MEDLINE Abstract

29 Tobe,V.O., Taylor,S.L. and Nickerson,D.A. (1996) Nucleic Acids Res., 24, 3728-3732. MEDLINE Abstract

30 Ju,J., Ruan,C., Fuller,C.W., Glazer,A.N. and Mathies,R.A. (1995) Proc. Natl. Acad. Sci. USA, 92, 4347-4351. MEDLINE Abstract

31 Metzker,M.L., Lu,J. and Gibbs,R.A. (1996) Science, 271, 1420-1402. MEDLINE Abstract

32 Kwok,P.-Y., Deng,Q., Zakeri,H., Taylor,S.L. and Nickerson,D.A. (1996) Genomics, 31, 123-126. MEDLINE Abstract

33 Grompe,M. (1993) Nature Genet., 5, 111-117. MEDLINE Abstract


*To whom correspondence should be addressed. Tel: +1 206 685 7387; Fax: +1 206 685 7301; Email: debnick@u.washington.edu
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Bot.Home page
A. Aguilar-Melendez, P. L. Morrell, M. L. Roose, and S.-C. Kim
Genetic diversity and structure in semiwild and domesticated chiles (Capsicum annuum; Solanaceae) from Mexico
Am. J. Botany, June 1, 2009; 96(6): 1190 - 1202.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
M. S. Udler, K. B. Meyer, K. A. Pooley, E. Karlins, J. P. Struewing, J. Zhang, D. R. Doody, S. MacArthur, J. Tyrer, P. D. Pharoah, et al.
FGFR2 variants and breast cancer risk: fine-scale mapping using African American studies and analysis of chromatin conformation
Hum. Mol. Genet., May 1, 2009; 18(9): 1692 - 1703.
[Abstract] [Full Text] [PDF]


Home page
Genome ResHome page
E. E. Smith and H. S. Malik
The apolipoprotein L family of programmed cell death and immunity genes rapidly evolved in primates at discrete sites of host-pathogen interactions
Genome Res., May 1, 2009; 19(5): 850 - 858.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. A. Johnson, M. Boyle, A. Bashashati, S. Leach, A. Brooks-Wilson, L. H. Sehn, M. Chhanabhai, R. R. Brinkman, J. M. Connors, A. P. Weng, et al.
Diffuse large B-cell lymphoma: reduced CD20 expression is associated with an inferior survival
Blood, April 16, 2009; 113(16): 3773 - 3780.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
S. Kashima, E. S. Rodrigues, R. Azevedo, E. da Cruz Castelli, C. T. Mendes-Junior, F. K. N. Yoshioka, I. T. da Silva, O. M. Takayanagui, and D. T. Covas
DC-SIGN (CD209) gene promoter polymorphisms in a Brazilian population and their association with human T-cell lymphotropic virus type 1 infection
J. Gen. Virol., April 1, 2009; 90(4): 927 - 934.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
M. M. Gray, J. M. Granka, C. D. Bustamante, N. B. Sutter, A. R. Boyko, L. Zhu, E. A. Ostrander, and R. K. Wayne
Linkage Disequilibrium and Demographic History of Wild and Domestic Canids
Genetics, April 1, 2009; 181(4): 1493 - 1505.
[Abstract] [Full Text] [PDF]


Home page
haematolHome page
N. A. Johnson, S. Leach, B. Woolcock, R. J. deLeeuw, A. Bashashati, L. H. Sehn, J. M. Connors, M. Chhanabhai, A. Brooks-Wilson, and R. D. Gascoyne
CD20 mutations involving the rituximab epitope are rare in diffuse large B-cell lymphomas and are not a significant cause of R-CHOP failure
Haematologica, March 1, 2009; 94(3): 423 - 427.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
J. L. Kelley, K. Turkheimer, M. Haney, and W. J. Swanson
Targeted resequencing of two genes, RAGE and POLL, confirms findings from a genome-wide scan for adaptive evolution and provides evidence for positive selection in additional populations
Hum. Mol. Genet., February 15, 2009; 18(4): 779 - 784.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
Y.-T. Chung, L.-L. Hsieh, I-H. Chen, C.-T. Liao, S.-H. Liou, C.-W. Chi, Y.-F. Ueng, and T.-Y. Liu
Sulfotransferase 1A1 haplotypes associated with oral squamous cell carcinoma susceptibility in male Taiwanese
Carcinogenesis, February 1, 2009; 30(2): 286 - 294.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
M. Carneiro, N. Ferrand, and M. W. Nachman
Recombination and Speciation: Loci Near Centromeres Are More Differentiated Than Loci Near Telomeres Between Subspecies of the European Rabbit (Oryctolagus cuniculus)
Genetics, February 1, 2009; 181(2): 593 - 606.
[Abstract] [Full Text] [PDF]


Home page
J HeredHome page
H. Chen, P. L. Morrell, V. E. T. M. Ashworth, M. de la Cruz, and M. T. Clegg
Tracing the Geographic Origins of Major Avocado Cultivars
J. Hered., January 1, 2009; 100(1): 56 - 65.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
M. H. Cho, D. Ciulla, B. J. Klanderman, B. A. Raby, and E. K. Silverman
High-Resolution Melting Curve Analysis of Genomic and Whole-Genome Amplified DNA
Clin. Chem., December 1, 2008; 54(12): 2055 - 2058.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. S. Ajioka, J. D. Phillips, R. B. Weiss, D. M. Dunn, M. W. Smit, S. C. Proll, M. G. Katze, and J. P. Kushner
Down-regulation of hepcidin in porphyria cutanea tarda
Blood, December 1, 2008; 112(12): 4723 - 4728.
[Abstract] [Full Text] [PDF]


Home page
Brief Funct Genomic ProteomicHome page
C. B. Moens, T. M. Donn, E. R. Wolf-Saxon, and T. P. Ma
Reverse genetics in zebrafish by TILLING
Brief Funct Genomic Proteomic, November 21, 2008; (2008) eln046v1.
[Abstract] [Full Text] [PDF]


Home page
Genome ResHome page
K. E. Varley and R. D. Mitra
Nested Patch PCR enables highly multiplexed mutation discovery in candidate genes
Genome Res., November 1, 2008; 18(11): 1844 - 1850.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
D A Koolen, A J Sharp, J A Hurst, H V Firth, S J L Knight, A Goldenberg, P Saugier-Veber, R Pfundt, L E L M Vissers, A Destree, et al.
Clinical and molecular delineation of the 17q21.31 microdeletion syndrome
J. Med. Genet., November 1, 2008; 45(11): 710 - 720.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
W. W. Laegreid, M. L. Clawson, M. P. Heaton, B. T. Green, K. I. O'Rourke, and D. P. Knowles
Scrapie Resistance in ARQ Sheep
J. Virol., October 15, 2008; 82(20): 10318 - 10320.
[Abstract] [Full Text] [PDF]


Home page
Syst BiolHome page
R. T. Brumfield, L. Liu, D. E. Lum, and S. V. Edwards
Comparison of Species Tree Methods for Reconstructing the Phylogeny of Bearded Manakins (Aves: Pipridae, Manacus) from Multilocus Sequence Data
Syst Biol, October 1, 2008; 57(5): 719 - 731.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. Wu, N. Jolicoeur, Z. Li, L. Zhang, Y. Fortin, D. L'Abbe, Z. Yu, and S.-H. Shen
Genetic variations of microRNAs in human cancer and their effects on the expression of miRNAs
Carcinogenesis, September 1, 2008; 29(9): 1710 - 1716.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
P. K. Ingvarsson
Multilocus Patterns of Nucleotide Polymorphism and the Demographic History of Populus tremula
Genetics, September 1, 2008; 180(1): 329 - 340.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
R. van Boxtel, P. W. Toonen, H. S. van Roekel, M. Verheul, B. M. G. Smits, J. Korving, A. de Bruin, and E. Cuppen
Lack of DNA mismatch repair protein MSH6 in the rat results in hereditary non-polyposis colorectal cancer-like tumorigenesis
Carcinogenesis, June 1, 2008; 29(6): 1290 - 1297.
[Abstract] [Full Text] [PDF]


Home page
BioinformaticsHome page
G. Denisov, B. Walenz, A. L. Halpern, J. Miller, N. Axelrod, S. Levy, and G. Sutton
Consensus generation and variant detection by Celera Assembler
Bioinformatics, April 15, 2008; 24(8): 1035 - 1040.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
S. Schlisio, R. S. Kenchappa, L. C.W. Vredeveld, R. E. George, R. Stewart, H. Greulich, K. Shahriari, N. V. Nguyen, P. Pigny, P. L. Dahia, et al.
The kinesin KIF1B{beta} acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor
Genes & Dev., April 1, 2008; 22(7): 884 - 893.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. E. Landers, A. L. Leclerc, L. Shi, A. Virkud, T. Cho, M. M. Maxwell, A. F. Henry, M. Polak, J. D. Glass, T. J. Kwiatkowski, et al.
New VAPB deletion variant and exclusion of VAPB mutations in familial ALS
Neurology, April 1, 2008; 70(14): 1179 - 1185.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Mokry and E. Cuppen
The Atp1a1 Gene From Inbred Dahl Salt Sensitive Rats Does Not Contain the A1079T Missense Transversion
Hypertension, April 1, 2008; 51(4): 922 - 927.
[Abstract] [Full Text] [PDF]


Home page
J HeredHome page
H. Chen, P. L. Morrell, M. de la Cruz, and M. T. Clegg
Nucleotide Diversity and Linkage Disequilibrium in Wild Avocado (Persea americana Mill.)
J. Hered., March 14, 2008; (2008) esn016v1.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
J. L. Kelley and W. J. Swanson
Dietary Change and Adaptive Evolution of enamelin in Humans and Among Primates
Genetics, March 1, 2008; 178(3): 1595 - 1603.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. J. Corenblum, V. E. Wise, K. Georgi, B. D. Hammock, P. A. Doris, and M. Fornage
Altered Soluble Epoxide Hydrolase Gene Expression and Function and Vascular Disease Risk in the Stroke-Prone Spontaneously Hypertensive Rat
Hypertension, February 1, 2008; 51(2): 567 - 573.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
J. Lamba, V. Lamba, S. Strom, R. Venkataramanan, and E. Schuetz
Novel Single Nucleotide Polymorphisms in the Promoter and Intron 1 of Human Pregnane X Receptor/NR1I2 and Their Association with CYP3A4 Expression
Drug Metab. Dispos., January 1, 2008; 36(1): 169 - 181.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. K. Lamba, K. Crews, S. Pounds, E. G. Schuetz, J. Gresham, V. Gandhi, W. Plunkett, J. Rubnitz, and R. Ribeiro
Pharmacogenetics of Deoxycytidine Kinase: Identification and Characterization of Novel Genetic Variants
J. Pharmacol. Exp. Ther., December 1, 2007; 323(3): 935 - 945.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
R. Zivadinov, B. Weinstock-Guttman, R. Benedict, M. Tamano-Blanco, S. Hussein, N. Abdelrahman, J. Durfee, and M. Ramanathan
Preservation of gray matter volume in multiple sclerosis patients with the Met allele of the rs6265 (Val66Met) SNP of brain-derived neurotrophic factor
Hum. Mol. Genet., November 15, 2007; 16(22): 2659 - 2668.
[Abstract] [Full Text] [PDF]


Home page
BioinformaticsHome page
J. E. Major
Genomic mutation consequence calculator
Bioinformatics, November 15, 2007; 23(22): 3091 - 3092.
[Abstract] [Full Text] [PDF]


Home page
Genome ResHome page
H. G. Parker, A. V. Kukekova, D. T. Akey, O. Goldstein, E. F. Kirkness, K. C. Baysac, D. S. Mosher, G. D. Aguirre, G. M. Acland, and E. A. Ostrander
Breed relationships facilitate fine-mapping studies: A 7.8-kb deletion cosegregates with Collie eye anomaly across multiple dog breeds
Genome Res., November 1, 2007; 17(11): 1562 - 1571.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
L. Fernandez, R. Milne, J Bravo, J. Lopez, J. Aviles, M. Longo, J Benitez, P Lazaro, and G Ribas
MC1R: three novel variants identified in a malignant melanoma association study in the Spanish population
Carcinogenesis, August 1, 2007; 28(8): 1659 - 1664.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
W. Barendse, B. E. Harrison, R. J. Hawken, D. M. Ferguson, J. M. Thompson, M. B. Thomas, and R. J. Bunch
Epistasis Between Calpain 1 and Its Inhibitor Calpastatin Within Breeds of Cattle
Genetics, August 1, 2007; 176(4): 2601 - 2610.
[Abstract] [Full Text] [PDF]


Home page
BioinformaticsHome page
F. Panitz, H. Stengaard, H. Hornshoj, J. Gorodkin, J. Hedegaard, S. Cirera, B. Thomsen, L. B. Madsen, A. Hoj, R. K. Vingborg, et al.
SNP mining porcine ESTs with MAVIANT, a novel tool for SNP evaluation and annotation
Bioinformatics, July 1, 2007; 23(13): i387 - i391.
[Abstract] [Full Text] [PDF]


Home page
BioinformaticsHome page
E. Dicks, J. W. Teague, P. Stephens, K. Raine, A. Yates, C. Mattocks, P. Tarpey, A. Butler, A. Menzies, D. Richardson, et al.
AutoCSA, an algorithm for high throughput DNA sequence variant detection in cancer genomes
Bioinformatics, July 1, 2007; 23(13): 1689 - 1691.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
V. Gonzalez-Covarrubias, D. Ghosh, S. S. Lakhman, L. Pendyala, and J. G. Blanco
A Functional Genetic Polymorphism on Human Carbonyl Reductase 1 (CBR1 V88I) Impacts on Catalytic Activity and NADPH Binding Affinity
Drug Metab. Dispos., June 1, 2007; 35(6): 973 - 980.
[Abstract] [Full Text] [PDF]


Home page
Genome ResHome page
E. Cuppen, E. Gort, E. Hazendonk, J. Mudde, J. van de Belt, I. J. Nijman, V. Guryev, and R. H.A. Plasterk
Efficient target-selected mutagenesis in Caenorhabditis elegans: Toward a knockout for every gene
Genome Res., May 1, 2007; 17(5): 649 - 658.
[Abstract] [Full Text] [PDF]


Home page
Genome ResHome page
K. Chen, M. D. McLellan, L. Ding, M. C. Wendl, Y. Kasai, R. K. Wilson, and E. R. Mardis
PolyScan: An automatic indel and SNP detection approach to the analysis of human resequencing data
Genome Res., May 1, 2007; 17(5): 659 - 666.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
Z. Jiang, Z. Wang, T. Kunej, G. A. Williams, J. J. Michal, X.-L. Wu, and N. S. Magnuson
A Novel Type of Sequence Variation: Multiple-Nucleotide Length Polymorphisms Discovered in the Bovine Genome
Genetics, May 1, 2007; 176(1): 403 - 407.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
B. M. Riley, M. A. Mansilla, J. Ma, S. Daack-Hirsch, B. S. Maher, L. M. Raffensperger, E. T. Russo, A. R. Vieira, C. Dode, M. Mohammadi, et al.
Impaired FGF signaling contributes to cleft lip and palate
PNAS, March 13, 2007; 104(11): 4512 - 4517.
[Abstract] [Full Text] [PDF]


Home page
Mol Biol EvolHome page
M. K. Shimada, K. Panchapakesan, S. A. Tishkoff, A. Q. Nato Jr, and J. Hey
Divergent Haplotypes and Human History as Revealed in a Worldwide Survey of X-Linked DNA Sequence Variation
Mol. Biol. Evol., March 1, 2007; 24(3): 687 - 698.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
I. Agalliu, E. M. Kwon, D. Zadory, L. McIntosh, J. Thompson, J. L. Stanford, and E. A. Ostrander
Germline Mutations in the BRCA2 Gene and Susceptibility to Hereditary Prostate Cancer
Clin. Cancer Res., February 1, 2007; 13(3): 839 - 843.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
W. Barendse, R. J. Bunch, J. W. Kijas, and M. B. Thomas
The Effect of Genetic Variation of the Retinoic Acid Receptor-Related Orphan Receptor C Gene on Fatness in Cattle
Genetics, February 1, 2007; 175(2): 843 - 853.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
V. J. Clark, S. E. Ptak, I. Tiemann, Y. Qian, G. Coop, A. C. Stone, M. Przeworski, N. Arnheim, and A. D. Rienzo
Combining Sperm Typing and Linkage Disequilibrium Analyses Reveals Differences in Selective Pressures or Recombination Rates Across Human Populations
Genetics, February 1, 2007; 175(2): 795 - 804.
[Abstract] [Full Text] [PDF]


Home page
Mol Biol EvolHome page
U Roostalu, I Kutuev, E-L Loogvali, E Metspalu, K Tambets, M Reidla, E. Khusnutdinova, E Usanga, T Kivisild, and R Villems
Origin and Expansion of Haplogroup H, the Dominant Human Mitochondrial DNA Lineage in West Eurasia: The Near Eastern and Caucasian Perspective
Mol. Biol. Evol., February 1, 2007; 24(2): 436 - 448.
[Abstract] [Full Text] [PDF]


Home page
Mol Biol EvolHome page
S. Seixas, G. Suriano, F. Carvalho, R. Seruca, J. Rocha, and A. Di Rienzo
Sequence Diversity at the Proximal 14q32.1 SERPIN Subcluster: Evidence for Natural Selection Favoring the Pseudogenization of SERPINA2
Mol. Biol. Evol., February 1, 2007; 24(2): 587 - 598.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
H.-J. Lenz, E. Van Cutsem, S. Khambata-Ford, R. J. Mayer, P. Gold, P. Stella, B. Mirtsching, A. L. Cohn, A. W. Pippas, N. Azarnia, et al.
Multicenter Phase II and Translational Study of Cetuximab in Metastatic Colorectal Carcinoma Refractory to Irinotecan, Oxaliplatin, and Fluoropyrimidines
J. Clin. Oncol., October 20, 2006; 24(30): 4914 - 4921.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
W.-P. Koh, J.-M. Yuan, D. Van Den Berg, S. A. Ingles, and M. C. Yu
Peroxisome proliferator-activated receptor (PPAR) {gamma} gene polymorphisms and colorectal cancer risk among Chinese in Singapore
Carcinogenesis, September 1, 2006; 27(9): 1797 - 1802.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
K. L. Bubb, D. Bovee, D. Buckley, E. Haugen, M. Kibukawa, M. Paddock, A. Palmieri, S. Subramanian, Y. Zhou, R. Kaul, et al.
Scan of Human Genome Reveals No New Loci Under Ancient Balancing Selection
Genetics, August 1, 2006; 173(4): 2165 - 2177.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
R. L. Parr, G. D. Dakubo, K. A. Crandall, J. Maki, B. Reguly, A. Aguirre, R. Wittock, K. Robinson, J. S. Alexander, M. A. Birch-Machin, et al.
Somatic Mitochondrial DNA Mutations in Prostate Cancer and Normal Appearing Adjacent Glands in Comparison to Age-Matched Prostate Samples without Malignant Histology
J. Mol. Diagn., July 1, 2006; 8(3): 312 - 319.
[Abstract] [Full Text] [PDF]


Home page
Vet PatholHome page
J. S. Johnson, W. S. Laegreid, R. J. Basaraba, and D. C. Baker
Truncated gamma-glutamyl carboxylase in rambouillet sheep.
Vet. Pathol., July 1, 2006; 43(4): 430 - 437.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
B. Mukherjee, O. E. Salavaggione, L. L. Pelleymounter, I. Moon, B. W. Eckloff, D. J. Schaid, E. D. Wieben, and R. M. Weinshilboum
GLUTATHIONE S-TRANSFERASE OMEGA 1 AND OMEGA 2 PHARMACOGENOMICS
Drug Metab. Dispos., July 1, 2006; 34(7): 1237 - 1246.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
J. M. Akey, W. J. Swanson, J. Madeoy, M. Eberle, and M. D. Shriver
TRPV6 exhibits unusual patterns of polymorphism and divergence in worldwide populations
Hum. Mol. Genet., July 1, 2006; 15(13): 2106 - 2113.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Bellanne-Chantelot, I. Chaumarel, M. Labopin, F. Bellanger, V. Barbu, C. De Toma, F. Delhommeau, N. Casadevall, W. Vainchenker, G. Thomas, et al.
Genetic and clinical implications of the Val617Phe JAK2 mutation in 72 families with myeloproliferative disorders
Blood, July 1, 2006; 108(1): 346 - 352.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
C. S. Carlson, J. D. Smith, I. B. Stanaway, M. J. Rieder, and D. A. Nickerson
Direct detection of null alleles in SNP genotyping data
Hum. Mol. Genet., June 15, 2006; 15(12): 1931 - 1937.
[Abstract] [Full Text] [PDF]


Home page
JDRHome page
A. Modesto, L.M. Moreno, K. Krahn, S. King, and A.C. Lidral
MSX1 and Orofacial Clefting with and without Tooth Agenesis
Journal of Dental Research, June 1, 2006; 85(6): 542 - 546.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
K. Yamamoto, J. Narukawa, K. Kadono-Okuda, J. Nohata, M. Sasanuma, Y. Suetsugu, Y. Banno, H. Fujii, M. R. Goldsmith, and K. Mita
Construction of a Single Nucleotide Polymorphism Linkage Map for the Silkworm, Bombyx mori, Based on Bacterial Artificial Chromosome End Sequences
Genetics, May 1, 2006; 173(1): 151 - 161.
[Abstract] [Full Text] [PDF]


Home page
Genome ResHome page
V. Guryev, M. J. Koudijs, E. Berezikov, S. L. Johnson, R. H.A. Plasterk, F. J.M. van Eeden, and E. Cuppen
Genetic variation in the zebrafish
Genome Res., April 1, 2006; 16(4): 491 - 497.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. C. Wood, O. E. Salavagionne, B. Mukherjee, L. Wang, A. F. Klumpp, B. A. Thomae, B. W. Eckloff, D. J. Schaid, E. D. Wieben, and R. M. Weinshilboum
Human Arsenic Methyltransferase (AS3MT) Pharmacogenetics: GENE RESEQUENCING AND FUNCTIONAL GENOMICS STUDIES
J. Biol. Chem., March 17, 2006; 281(11): 7364 - 7373.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. A. Gilbert, O. E. Salavaggione, Y. Ji, L. L. Pelleymounter, B. W. Eckloff, E. D. Wieben, M. M. Ames, and R. M. Weinshilboum
Gemcitabine pharmacogenomics: cytidine deaminase and deoxycytidylate deaminase gene resequencing and functional genomics.
Clin. Cancer Res., March 15, 2006; 12(6): 1794 - 1803.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
E. Sturenburg, N. Storm, I. Sobottka, M. A. Horstkotte, S. Scherpe, M. Aepfelbacher, and S. Muller
Detection and Genotyping of SHV {beta}-Lactamase Variants by Mass Spectrometry after Base-Specific Cleavage of In Vitro-Generated RNA Transcripts.
J. Clin. Microbiol., March 1, 2006; 44(3): 909 - 915.
[Abstract] [Full Text] [PDF]


Home page
BioinformaticsHome page
D. Huntley, A. Baldo, S. Johri, and M. Sergot
SEAN: SNP prediction and display program utilizing EST sequence clusters
Bioinformatics, February 15, 2006; 22(4): 495 - 496.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. C. Greiner, C. Dasgupta, V. V. Ho, D. D. Weisenburger, L. M. Smith, J. C. Lynch, J. M. Vose, K. Fu, J. O. Armitage, R. M. Braziel, et al.
Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma
PNAS, February 14, 2006; 103(7): 2352 - 2357.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
I. Cheng, D. O. Stram, K. L. Penney, M. Pike, L. Le Marchand, L. N. Kolonel, J. Hirschhorn, D. Altshuler, B. E. Henderson, and M. L. Freedman
Common Genetic Variation in IGF1 and Prostate Cancer Risk in the Multiethnic Cohort
J Natl Cancer Inst, January 18, 2006; 98(2): 123 - 134.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
B. F. Voight, A. M. Adams, L. A. Frisse, Y. Qian, R. R. Hudson, and A. Di Rienzo
Interrogating multiple aspects of variation in a full resequencing data set to infer human population size changes
PNAS, December 20, 2005; 102(51): 18508 - 18513.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
Z. Tan, A. M. Shon, and C. Ober
Evidence of balancing selection at the HLA-G promoter region
Hum. Mol. Genet., December 1, 2005; 14(23): 3619 - 3628.
[Abstract] [Full Text] [PDF]


Home page
JDRHome page
J. Zhou, Y. Lu, X.H. Gao, Y.C. Chen, J.J. Lu, Y.X. Bai, Y. Shen, and B.K. Wang
The Growth Hormone Receptor Gene is Associated with Mandibular Height in a Chinese Population
Journal of Dental Research, November 1, 2005; 84(11): 1052 - 1056.
[Abstract] [Full Text] [PDF]


Home page
Genome ResHome page
P. Hallast, L. Nagirnaja, T. Margus, and M. Laan
Segmental duplications and gene conversion: Human luteinizing hormone/chorionic gonadotropin {beta} gene cluster
Genome Res., November 1, 2005; 15(11): 1535 - 1546.
[Abstract] [Full Text] [PDF]


Home page
Genome ResHome page
C. S. Carlson, D. J. Thomas, M. A. Eberle, J. E. Swanson, R. J. Livingston, M. J. Rieder, and D. A. Nickerson
Genomic regions exhibiting positive selection identified from dense genotype data
Genome Res., November 1, 2005; 15(11): 1553 - 1565.
[Abstract] [Full Text] [PDF]


Home page
J HeredHome page
S. Tacher, P. Quignon, M. Rimbault, S. Dreano, C. Andre, and F. Galibert
Olfactory Receptor Sequence Polymorphism Within and Between Breeds of Dogs
J. Hered., November 1, 2005; 96(7): 812 - 816.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
R. D. Read, P. J. Goodfellow, E. R. Mardis, N. Novak, J. R. Armstrong, and R. L. Cagan
A Drosophila Model of Multiple Endocrine Neoplasia Type 2
Genetics, November 1, 2005; 171(3): 1057 - 1081.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Y. Signorovitch, S. L. Dellaporta, and L. W. Buss
Molecular signatures for sex in the Placozoa
PNAS, October 25, 2005; 102(43): 15518 - 15522.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
S. J. Lindsay, J. K. Bonfield, and M. E. Hurles
Shotgun haplotyping: a novel method for surveying allelic sequence variation
Nucleic Acids Res., October 12, 2005; 33(18): e152 - e152.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
B. M. G. Smits, T. A. Peters, J. D. Mul, H. J. Croes, J. A. M. Fransen, A. J. Beynon, V. Guryev, R. H. A. Plasterk, and E. Cuppen
Identification of a Rat Model for Usher Syndrome Type 1B by N-Ethyl-N-nitrosourea Mutagenesis-Driven Forward Genetics
Genetics, August 1, 2005; 170(4): 1887 - 1896.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
Y.-F. Liu, W.-M. Chen, Y.-F. Lin, R.-C. Yang, M.-W. Lin, L.-H. Li, Y.-H. Chang, Y.-S. Jou, P.-Y. Lin, J.-S. Su, et al.
Type II Collagen Gene Variants and Inherited Osteonecrosis of the Femoral Head
N. Engl. J. Med., June 2, 2005; 352(22): 2294 - 2301.
[Abstract] [Full Text] [PDF]


Home page
Proc R Soc BHome page
S. V Edwards, W Bryan Jennings, and A. M Shedlock
Phylogenetics of modern birds in the era of genomics
Proc R Soc B, May 22, 2005; 272(1567): 979 - 992.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
R. Weikard, C. Kuhn, T. Goldammer, G. Freyer, and M. Schwerin
The bovine PPARGC1A gene: molecular characterization and association of an SNP with variation of milk fat synthesis
Physiol Genomics, March 21, 2005; 21(1): 1 - 13.
[Abstract] [Full Text] [PDF]


Home page
Genome ResHome page
S. Weckx, J. Del-Favero, R. Rademakers, L. Claes, M. Cruts, P. De Jonghe, C. Van Broeckhoven, and P. De Rijk
novoSNP, a novel computational tool for sequence variation discovery
Genome Res., March 1, 2005; 15(3): 436 - 442.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. L. Morrell, D. M. Toleno, K. E. Lundy, and M. T. Clegg
Low levels of linkage disequilibrium in wild barley (Hordeum vulgare ssp. spontaneum) despite high rates of self-fertilization
PNAS, February 15, 2005; 102(7): 2442 - 2447.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
S. S. Lakhman, D. Ghosh, and J. G. Blanco
FUNCTIONAL SIGNIFICANCE OF A NATURAL ALLELIC VARIANT OF HUMAN CARBONYL REDUCTASE 3 (CBR3)
Drug Metab. Dispos., February 1, 2005; 33(2): 254 - 257.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
I. L. Sedlmeyer, C. L. Pearce, J. A. Trueman, J. L. Butler, T. Bersaglieri, A. P. Read, P. E. Clayton, L. N. Kolonel, B. E. Henderson, J. N. Hirschhorn, et al.
Determination of Sequence Variation and Haplotype Structure for the Gonadotropin-Releasing Hormone (GnRH) and GnRH Receptor Genes: Investigation of Role in Pubertal Timing
J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 1091 - 1099.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
J. D. Hurley, L. J. Engle, J. T. Davis, A. M. Welsh, and J. E. Landers
A simple, bead-based approach for multi-SNP molecular haplotyping
Nucleic Acids Res., January 6, 2005; 32(22): e186 - e186.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
E. Green, G. Elvidge, N. Jacobsen, B. Glaser, I. Jones, M. C. O'Donovan, G. Kirov, M. J. Owen, and N. Craddock
Localization of Bipolar Susceptibility Locus by Molecular Genetic Analysis of the Chromosome 12q23-q24 Region in Two Pedigrees With Bipolar Disorder and Darier's Disease
Am J Psychiatry, January 1, 2005; 162(1): 35 - 42.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
T. R. Bhangale, M. J. Rieder, R. J. Livingston, and D. A. Nickerson
Comprehensive identification and characterization of diallelic insertion-deletion polymorphisms in 330 human candidate genes
Hum. Mol. Genet., January 1, 2005; 14(1): 59 - 69.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
H. G. Olsen, S. Lien, M. Gautier, H. Nilsen, A. Roseth, P. R. Berg, K. K. Sundsaasen, M. Svendsen, and T. H. E. Meuwissen
Mapping of a Milk Production Quantitative Trait Locus to a 420-kb Region on Bovine Chromosome 6
Genetics, January 1, 2005; 169(1): 275 - 283.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
H. Kondo, M. Qin, A. Mizota, M. Kondo, H. Hayashi, K. Hayashi, K. Oshima, T. Tahira, and K. Hayashi
A Homozygosity-Based Search for Mutations in Patients with Autosomal Recessive Retinitis Pigmentosa, Using Microsatellite Markers
Invest. Ophthalmol. Vis. Sci., December 1, 2004; 45(12): 4433 - 4439.
[Abstract] [Full Text] [PDF]


Home page
Genome ResHome page
N. B. Sutter, M. A. Eberle, H. G. Parker, B. J. Pullar, E. F. Kirkness, L. Kruglyak, and E. A. Ostrander
Extensive and breed-specific linkage disequilibrium in Canis familiaris
Genome Res., December 1, 2004; 14(12): 2388 - 2396.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
L. Zhang, F. Rao, J. Wessel, B. P. Kennedy, B. K. Rana, L. Taupenot, E. O. Lillie, M. Cockburn, N. J. Schork, M. G. Ziegler, et al.
Functional allelic heterogeneity and pleiotropy of a repeat polymorphism in tyrosine hydroxylase: prediction of catecholamines and response to stress in twins
Physiol Genomics, November 17, 2004; 19(3): 277 - 291.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
D. Concepcion, K. L. Seburn, G. Wen, W. N. Frankel, and B. A. Hamilton
Mutation Rate and Predicted Phenotypic Target Sizes in Ethylnitrosourea-Treated Mice
Genetics, October 1, 2004; 168(2): 953 - 959.
[Abstract] [Full Text] [PDF]


Home page
Genome ResHome page
R. J. Livingston, A. von Niederhausern, A. G. Jegga, D. C. Crawford, C. S. Carlson, M. J. Rieder, S. Gowrisankar, B. J. Aronow, R. B. Weiss, and D. A. Nickerson
Pattern of Sequence Variation Across 213 Environmental Response Genes
Genome Res., October 1, 2004; 14(10a): 1821 - 1831.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
M. S. Anglesio, V. Evdokimova, N. Melnyk, L. Zhang, C. V. Fernandez, P. E. Grundy, S. Leach, M. A. Marra, A. R. Brooks-Wilson, J. Penninger, et al.
Differential expression of a novel ankyrin containing E3 ubiquitin-protein ligase, Hace1, in sporadic Wilms' tumor versus normal kidney
Hum. Mol. Genet., September 15, 2004; 13(18): 2061 - 2074.
[Abstract] [Full Text] [PDF]


Home page
JDRHome page
A.R. Vieira, R. Meira, A. Modesto, and J.C. Murray
MSX1, PAX9, and TGFA Contribute to Tooth Agenesis in Humans
Journal of Dental Research, September 1, 2004; 83(9): 723 - 727.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
M. Olivier, C. A. Hsiung, L.-M. Chuang, L.-T. Ho, C.-T. Ting, V. I. Bustos, T. M. Lee, A. de Witte, Y.-D. I. Chen, R. Olshen, et al.
Single nucleotide polymorphisms in protein tyrosine phosphatase 1{beta} (PTPN1) are associated with essential hypertension and obesity
Hum. Mol. Genet., September 1, 2004; 13(17): 1885 - 1892.
[Abstract] [Full Text] [PDF]


Home page
Genome ResHome page
B. M.G. Smits, B. F.M. van Zutphen, R. H.A. Plasterk, and E. Cuppen
Genetic Variation in Coding Regions Between and Within Commonly Used Inbred Rat Strains
Genome Res., July 1, 2004; 14(7): 1285 - 1290.
[Abstract] [Full Text] [PDF]


Home page
Genome ResHome page
V. Guryev, E. Berezikov, R. Malik, R. H.A. Plasterk, and E. Cuppen
Single Nucleotide Polymorphisms Associated With Rat Expressed Sequences
Genome Res., July 1, 2004; 14(7): 1438 - 1443.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Print PDF (938K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (540)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Nickerson, D. A.
Right arrow Articles by Taylor, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nickerson, D. A.
Right arrow Articles by Taylor, S. L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?